Spindle cell rhabdomyosarcoma: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tag: Reverted
No edit summary
Tag: Manual revert
 
Line 27: Line 27:
{{stub}}
{{stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 18:47, 18 March 2025

Spindle cell rhabdomyosarcoma is a rare subtype of rhabdomyosarcoma, a type of cancer that develops from skeletal muscle cells. It is characterized by elongated, spindle-shaped cells, and is most commonly found in the head and neck, genitourinary tract, and retroperitoneum.

Epidemiology[edit]

Spindle cell rhabdomyosarcoma is a rare form of cancer, accounting for less than 3% of all rhabdomyosarcomas. It is most commonly diagnosed in children and young adults, but can occur at any age.

Pathology[edit]

The tumor is composed of elongated, spindle-shaped cells that resemble fibroblasts. These cells are arranged in a pattern that resembles a herringbone or fascicular pattern. The cells often express desmin, a protein that is typically found in muscle cells.

Diagnosis[edit]

The diagnosis of spindle cell rhabdomyosarcoma is typically made through a combination of imaging studies, biopsy, and histopathological examination. Immunohistochemistry is often used to confirm the diagnosis, with the tumor cells typically expressing desmin and other muscle-specific proteins.

Treatment[edit]

The treatment of spindle cell rhabdomyosarcoma typically involves a combination of surgery, radiation therapy, and chemotherapy. The specific treatment plan is determined based on the size and location of the tumor, the patient's overall health, and other factors.

Prognosis[edit]

The prognosis for patients with spindle cell rhabdomyosarcoma is generally poor, with a 5-year survival rate of less than 50%. However, the prognosis can vary widely depending on the size and location of the tumor, the patient's overall health, and other factors.

See also[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia